174 related articles for article (PubMed ID: 16681304)
1. Biological therapy for psoriasis.
Clements SE; Abdul-Ghaffar S; Griffiths CE
Br J Hosp Med (Lond); 2006 Apr; 67(4):184-7. PubMed ID: 16681304
[No Abstract] [Full Text] [Related]
2. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept.
Weinberg JM; Saini R
Cutis; 2003 Jan; 71(1):25-9. PubMed ID: 12553627
[TBL] [Abstract][Full Text] [Related]
3. Biologic therapeutics in the treatment of psoriasis. Part 1: review.
Langley RG; Gupta AK; Cherman AM; Inniss KA
J Cutan Med Surg; 2007; 11(3):99-122. PubMed ID: 17511926
[TBL] [Abstract][Full Text] [Related]
4. Update on the mechanisms and efficacy of biological therapies for psoriasis.
Koo J; Khera P
J Dermatol Sci; 2005 May; 38(2):75-87. PubMed ID: 15862940
[TBL] [Abstract][Full Text] [Related]
5. Biologic therapy for psoriasis--the first wave: infliximab, etanercept, efalizumab, and alefacept.
Weinberg JM; Saini R; Tutrone WD
J Drugs Dermatol; 2002 Dec; 1(3):303-10. PubMed ID: 12851990
[TBL] [Abstract][Full Text] [Related]
6. [The role of biological drugs in the treatment of psoriasis, results from 9 randomized placebo-controlled trials].
Kemény L; Brodszky V; Kárpáti K; Gulácsi L
Orv Hetil; 2006 May; 147(21):981-90. PubMed ID: 16812973
[TBL] [Abstract][Full Text] [Related]
7. Understanding the new clinical landscape for psoriasis: a comparative review of biologics.
Sauder DN; Mamelak AJ
J Cutan Med Surg; 2004; 8(4):205-12. PubMed ID: 16091996
[TBL] [Abstract][Full Text] [Related]
8. Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies.
Prignano F; Ricceri F; Pescitelli L; Buggiani G; Troiano M; Zanieri F; Rossari S; Lotti T
Curr Med Res Opin; 2009 Sep; 25(9):2311-6. PubMed ID: 19635043
[TBL] [Abstract][Full Text] [Related]
9. The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis.
Katugampola RP; Lewis VJ; Finlay AY
Br J Dermatol; 2007 May; 156(5):945-50. PubMed ID: 17388922
[TBL] [Abstract][Full Text] [Related]
10. Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept.
Weinberg JM; Bottino CJ; Lindholm J; Buchholz R
J Drugs Dermatol; 2005; 4(5):544-55. PubMed ID: 16167412
[TBL] [Abstract][Full Text] [Related]
11. Consecutive use of different biological therapies in the treatment of psoriasis.
Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
[No Abstract] [Full Text] [Related]
12. Systemic therapies for psoriasis: understanding current and newly emerging therapies.
Sobell JM; Hallas SJ
Semin Cutan Med Surg; 2003 Sep; 22(3):187-95. PubMed ID: 14649586
[TBL] [Abstract][Full Text] [Related]
13. Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
Kalb RE; Blauvelt A; Sofen HL; Chevrier M; Amato D; Calabro S; Wang J; Schenkel B; Gottlieb AB
J Drugs Dermatol; 2013 Aug; 12(8):874-80. PubMed ID: 23986160
[TBL] [Abstract][Full Text] [Related]
14. [Biologic therapy and psoriasis].
Gamo R; López-Estebaranz JL
Actas Dermosifiliogr; 2006; 97(1):1-17. PubMed ID: 16540046
[TBL] [Abstract][Full Text] [Related]
15. A review of biologic treatments for psoriasis with emphasis on infliximab.
Pirzada S; Tomi Z; Gulliver W
Skin Therapy Lett; 2007 Apr; 12(3):1-4. PubMed ID: 17487347
[TBL] [Abstract][Full Text] [Related]
16. Biological agents in the treatment of psoriasis.
Tzu J; Krulig E; Cardenas V; Kerdel FA
G Ital Dermatol Venereol; 2008 Oct; 143(5):315-27. PubMed ID: 18833073
[TBL] [Abstract][Full Text] [Related]
17. [Biologics in skin diseases other than psoriasis].
Gniadecki R; Skov L
Ugeskr Laeger; 2008 Jun; 170(24):2126-8. PubMed ID: 18565293
[TBL] [Abstract][Full Text] [Related]
18. Comparing biological therapies in psoriasis: implications for clinical practice.
Griffiths CE
J Eur Acad Dermatol Venereol; 2010 Oct; 24 Suppl 6():10-4. PubMed ID: 20831704
[TBL] [Abstract][Full Text] [Related]
19. A new era in the management of psoriasis? The biologics: facts and controversies.
Ferrándiz C; Carrascosa JM; Boada A
Clin Dermatol; 2010; 28(1):81-7. PubMed ID: 20082956
[TBL] [Abstract][Full Text] [Related]
20. Experience with biologics for psoriasis in daily practice: switching is worth a try.
Lecluse LL; de Groot M; Bos JD; Spuls PI
Br J Dermatol; 2009 Oct; 161(4):948-51. PubMed ID: 19663876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
